Work

Effects of CYP2C19 genetic polymorphism on the steady-state concentration of citalopram in patients with major depressive disorder

Year: 2021

Type: article

Source: The Pharmacogenomics Journal

DOI: 10.1038/s41397-021-00219-7

Authors: M. S. Zastrozhin, V. Yu Skryabin, A. E. Petukhov, M. V. Torrado, E. P. Pankratenko, A. K. Zastrozhina, E. A. Grishina, K. A. Ryzhikova, V. V. Shipitsyn, E. A. Bryun, D. A. Sychev

Institutions: Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation, Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Sechenov University, University of Lisbon

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3129367262

FWCI: 1.181

Cites: 15

Cited by: 10

Related to: 10